BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Amniocentesis
,
Rosiglitazone
,
rs4950928
,
VEGFA
,
T cell receptor signaling pathway
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
XM_001101107
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Hematopoietic stem cell of bone marrow
Superior cervical ganglion
B lymphocyte (IgM memory) of spleen
Appendix
Monocyte of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Blockade of OX40/OX40L signaling using anti-OX40L alleviates murine lupus nephritis.
The role of OX40 ligand/OX40 axis signalling in atopic dermatitis.
Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colore…
Human OX40L-CAR-Tregs target activated antigen-presenting cells and control T cell alloreactivity.
OX40 Ligand-Mannose-Binding Lectin Fusion Protein Induces Potent OX40 Cosignaling in CD4+ T Cells.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for XM_001101107
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ